Literature DB >> 14639586

Gelsolin-related familial amyloidosis, Finnish type, in a Portuguese family: clinical and neurophysiological studies.

Isabel Conceição1, Maria Lurdes Sales-Luis, Mamede De Carvalho, Teresinha Evangelista, Rui Fernandes, Tiina Paunio, Hannele Kangas, Paula Coutinho, Carlos Neves, Maria João Saraiva.   

Abstract

We report a Portuguese family with familial amyloid polyneuropathy related to gelsolin. There were no known Finnish ancestors, but the same mutation as described in Finnish patients (G654A) was carried. Clinical and neurophysiological investigations were performed in four patients. Corneal lattice dystrophy affected all four patients; an axonal lesion of the facial nerve occurred in three patients; visual tract involvement was documented in one case; and corticospinal and posterior column dysfunction was present in one patient. Polarizing microscopy of skin and muscle samples demonstrated amyloid deposits in two patients; anti-gelsolin immunohistochemistry was positive for amyloidogenic gelsolin. The Finnish mutation of gelsolin protein (G654A) was detected in five family members. The utility of neurophysiological testing in the evaluation and follow-up of this type of amyloidosis is discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14639586     DOI: 10.1002/mus.10474

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  7 in total

Review 1.  Gelsolin amyloidosis: genetics, biochemistry, pathology and possible strategies for therapeutic intervention.

Authors:  James P Solomon; Lesley J Page; William E Balch; Jeffery W Kelly
Journal:  Crit Rev Biochem Mol Biol       Date:  2012-02-24       Impact factor: 8.250

2.  Clinical features and haplotype analysis of newly identified Japanese patients with gelsolin-related familial amyloidosis of Finnish type.

Authors:  Makiko Taira; Hiroyuki Ishiura; Jun Mitsui; Yuji Takahashi; Toshihiro Hayashi; Jun Shimizu; Takashi Matsukawa; Naoko Saito; Kazumasa Okada; Sadatoshi Tsuji; Hiromasa Sawamura; Shiro Amano; Jun Goto; Shoji Tsuji
Journal:  Neurogenetics       Date:  2012-05-24       Impact factor: 2.660

3.  The First Argentinian Family with Familial Amyloidosis of the Finnish Type.

Authors:  Francisco Lucero Saá; Federico Andrés Cremona; Natalia Ximena Mínguez; María Laura Igarzabal; Pablo Chiaradía
Journal:  Case Rep Ophthalmol       Date:  2017-08-31

4.  The role of gelsolin domain 3 in familial amyloidosis (Finnish type).

Authors:  Habiba Zorgati; Mårten Larsson; Weitong Ren; Adelene Y L Sim; Jan Gettemans; Jonathan M Grimes; Wenfei Li; Robert C Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-26       Impact factor: 11.205

5.  Clinical, histopathological, and in silico pathogenicity analyses in a pedigree with familial amyloidosis of the Finnish type (Meretoja syndrome) caused by a novel gelsolin mutation.

Authors:  Jesus Cabral-Macias; Leopoldo A Garcia-Montaño; Mario Pérezpeña-Díazconti; Marisa-Cruz Aguilar; Guillermo Garcia; Carlos I Vencedor-Meraz; Enrique O Graue-Hernandez; Oscar F Chacón-Camacho; Juan C Zenteno
Journal:  Mol Vis       Date:  2020-05-02       Impact factor: 2.367

6.  Clinical Features and Brain MRI Findings in Korean Patients with AGel Amyloidosis.

Authors:  E Nae Cheong; Wooyul Paik; Young Chul Choi; Young Min Lim; Hyunjin Kim; Woo Hyun Shim; Hyung Jun Park
Journal:  Yonsei Med J       Date:  2021-05       Impact factor: 2.759

7.  Analyses Mutations in GSN, CST3, TTR, and ITM2B Genes in Chinese Patients With Alzheimer's Disease.

Authors:  Yaling Jiang; Bin Jiao; Xinxin Liao; Xuewen Xiao; Xixi Liu; Lu Shen
Journal:  Front Aging Neurosci       Date:  2020-09-10       Impact factor: 5.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.